News
Valo Health bags $2.7bn AI partnership with Novo Nordisk
Novo Nordisk has paid $60 million to partner Valo Health on a project …
19804 items found
Digital
Post-pandemic reality hits digital health hard
The fall of Babylon Health marks the second major collapse of a …
News
Polpharma Bio gets first EU okay for Tysabri biosimilar
Polpharma Biologics has said it is the first company to get approval …
News
CDC backs maternal use of Pfizer’s RSV vaccine
The way has been largely cleared for the rollout of Pfizer’s …
R&D
Partner Content
News
Boehringer backs NHS trust programme for diabetics
An alliance between German pharma group Boehringer Ingelheim and an …
News
Novartis eyes first-line use of Lutathera after trial win
Novartis is preparing to file for approval of its radioligand therapy …
News
AI tech to cut waiting lists rolls out across NHS region
With waiting lists in the UK staying stubbornly above the 7 million …
R&D
How AI is propelling pharma into the modern age
Artificial intelligence’s role in drug discovery is apparent and …
News
Leqembi approved in Japan, its first ex-US market
Eisai and Biogen now have their second regulatory approval for …
Oncology
R&D
Partner Content
5th Inflammasome Therapeutics Summit returns to Boston!
The 5th Inflammasome Therapeutics Summit returns to Boston to unite …
R&D
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal...
Cassava is advancing simufilam through a pivotal phase 3 trial, despite lingering controversy from a SEC investigation.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Sales & Marketing
Sponsored
Seeking a single source of truth: Standardisation of the dat...
Oskar Mӧbert, Vice President of OpenData at Veeva Systems, spoke with Ian Cornish, Associate Director of Data Platforms at Astellas, about the company’s decision to opt into Veeva’s OpenDat
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
EHS&S for Biopharma & Pharma Summit
Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities
R&D
Partner Content
Proteomic Based Drug Discovery Summit 2025
Determine Optimum Application of Proteomics to Accelerate Screening of Novel Targets, Unravel the Mode of Action, & Identify Biomarkers to Progress Small Molecule Drug Discovery & T
